In a report released today, Peter Welford from Jefferies downgraded GlaxoSmithKline (GSK – Research Report) to a Hold, with a price ...

GSK celebrates 100 years in India with former MDs, highlighting resilience and reinvention in the pharmaceutical industry.

“I definitely didn’t foresee that there’ll be so many fires to put out,” says the head of HR at BASF. “There’s a lot of ...

Concluded targeted enrollment of Phase 3 INDIGO trial evaluating obexelimab for the treatment of Immunoglobulin G4-Related ...

The Nasal Drug Delivery Technology Market is driven by the rising demand for non-invasive administration methods that enhance patient compliance and bioavailability. Innovations such as advanced ...

DelveInsight's 'NK Cell Therapy Pipeline Insight 2024' report provides comprehensive global coverage of pipeline NK cell ...

The company’s shares opened today at p10,290.00. Welford covers the Healthcare sector, focusing on stocks such as Sanofi, GlaxoSmithKline, and Novartis. According to TipRanks, Welford has an average ...

Andrew Witty became CEO of UnitedHealth Group in 2021, but this isn’t his first medical executive gig—he also served as CEO ...

Says medical devices market to grow by 10.8% amid Naira depreciation By Peter Egwuatu Fitch Solutions, a ...

The Pakistani rupee saw a slight uptick against the US dollar during early trading on Tuesday, gaining 0.04% in the ...

Topline Securities Ltd said the index was lifted by positive contributions from Oil and Gas Development Company Ltd, Pakistan ...